HansBiomed Corporation

KOSDAQ:A042520 Rapporto sulle azioni

Cap. di mercato: ₩129.4b

La traduzione di questa pagina è sperimentale e in fase di sviluppo. Siamo lieti di ricevere vostro !

HansBiomed Gestione

Gestione criteri di controllo 0/4

Al momento non disponiamo di informazioni sufficienti sull'amministratore delegato.

Informazioni chiave

Guen Young Kim

Amministratore delegato

n/a

Compenso totale

Percentuale dello stipendio del CEOn/a
Mandato del CEO3.7yrs
Proprietà del CEOn/a
Durata media del managementNessun dato
Durata media del Consiglio di amministrazioneNessun dato

Aggiornamenti recenti sulla gestione

Recent updates

Is HansBiomed (KOSDAQ:042520) A Risky Investment?

Feb 29
Is HansBiomed (KOSDAQ:042520) A Risky Investment?

HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth

Feb 29
HansBiomed Corporation (KOSDAQ:042520) Shares Fly 25% But Investors Aren't Buying For Growth

Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?

Apr 10
Are Dividend Investors Making A Mistake With HansBiomed Corporation (KOSDAQ:042520)?

Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?

Mar 06
Does HansBiomed (KOSDAQ:042520) Have A Healthy Balance Sheet?

HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.

Jan 30
HansBiomed's(KOSDAQ:042520) Share Price Is Down 63% Over The Past Three Years.

Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Dec 08
Are HansBiomed's (KOSDAQ:042520) Statutory Earnings A Good Reflection Of Its Earnings Potential?

Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?

Nov 20
Declining Stock and Decent Financials: Is The Market Wrong About HansBiomed Corporation (KOSDAQ:042520)?

AMMINISTRATORE DELEGATO

Guen Young Kim

3.7yrs

Mandato

Guen Young Kim serves as Chief Executive Officer of HansBiomed Corp. since January 2021.